Lindy Biosciences, Inc.
Biotherapeutic drug formulations enabling home administration
- Sector
- Biotech
- Headquarters
- Morrisville, NC
- Founded
- 2016
- Latest Form D
- $1.7M, Mar 2024
- Total capital
- $5.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5.7M
- 4 Form D · last Mar 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2023
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$1.7M
- Private capital raisedForm D · SEC · 3rd filing$3.3M
- Private capital raisedForm D · SEC · 2nd filing$548K
- Private capital raisedForm D · SEC · 1st filing$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Deborah BitterfieldExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Joel WhitleyDirectorNamed in SEC Form D filings
- Karen LeVertDirectorNamed in SEC Form D filings
- Omar FloresExecutive Officer, DirectorNamed in SEC Form D filings
- Sreekar GaddeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- GrantedCompositions Comprising Solid ParticlesUSPTOUS 11,795,429
- PendingIsolated Cell Culture Components And Methods For Isolating The Same From Liquid Cell Culture MediumUSPTOApplication 17428063
- PendingHyaluronidase Particles, Compositions Comprising The Same And Methods Of Making And Using The SameUSPTOApplication PCTUS2024016360
Show all 5 patent records
- Compositions Comprising Solid ParticlesOct 24, 2023 · US 11,795,429Granted
- Isolated Cell Culture Components And Methods For Isolating The Same From Liquid Cell Culture MediumApr 21, 2022 · Application 17428063Pending
- Hyaluronidase Particles, Compositions Comprising The Same And Methods Of Making And Using The SameApplication PCTUS2024016360Pending
- Isolated Cell Culture Components And Methods For Isolating The Same From Liquid Cell Culture MediumApplication PCTUS2020016743Pending
- Hyaluronidase Particles, Compositions Comprising The Same And Methods Of Making And Using The SameApplication 19156476Pending
Related companies, and why
- Terremoto BiosciencesSimilar federal contract value in Biotech · null in contracts
- NephroDI Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Cerebral TherapeuticsSimilar federal contract value in Biotech · null in contracts
- NewcelX Ltd.Similar federal contract value in Biotech · null in contracts
- HCW Biologics Inc.Similar federal contract value in Biotech · null in contracts
- Onchilles Pharma, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .